Haɓaka ingantaccen bincike na cututtuka

Jinkirin ganewar cututtuka na cututtuka masu yaduwa sanya yawan jama'a cikin haɗari a cikin duniyarmu ta duniya, musamman tare da cututtukan zoonotic da ke yaduwa tsakanin dabbobi da mutane. Kimanin kashi 75 cikin 100 na sabbin cututtukan cututtukan mutane 30 da aka yi rikodin a cikin shekaru 30 da suka gabata a cikin 2008 daga dabbobi ne, a cewar rahoton WHO da aka fitar a cikin 2021.

"An sadaukar da ƙungiyarmu don shawo kan ƙalubalen ƙira na bincike don biyan buƙatun bincike don saurin POCT da samun dama a cikin duka IVD.in-vitro) da kuma wadanda ba IVD ba, "in ji Lianyi Xie, wanda ya kafa Hangzhou Bigfish Bio-tech Co., Ltd, a cikin 2017. "An tsara gwajin gwajin mu na kulawa (POCT) don yin aiki da sauri a cikin iyakokin albarkatun kasa, yayin cin abinci. don nau'ikan cututtuka daban-daban."

An ƙera POCTs na Bigfish don kiyaye lafiyar abinci, da lafiyar dabbobi da dabbobi, musamman idan aka yi la'akari da karuwar masu mallakar dabbobin China.

Yarjejeniyar ƙirar POCT mai sauri, Xie ya bayyana, dole ne ta daidaita daidaito tsakanin ƙididdigewa da mai da hankali kan fasahar haɓakawa na gargajiya da abin dogaro, dangane da sarkar polymerase (PCR), don gano adadin adadin acid nucleic na mintuna daga hadaddun kafofin watsa labarai.

Yi la'akari da barkewar cutar zazzabin aladu ta Afirka (ASF) a kasar Sin, gida ga kasuwar noman alade mafi girma a duniya. A cikin 2019, ASF ta haifar da mutuwar aladu sama da miliyan 43, kuma kusan dala biliyan 111 na asara. Ƙirƙirar ƙirar POCT ta dogara da haɗin gwiwa tare da ƙungiyoyin ilimi da na gwamnati, da kuma martani daga masu amfani, kamar manyan masu kiwon alade na kasar Sin.

Xie ya ce "Sahihanci da sanin yakamata dangane da saitunan dakin gwaje-gwaje, har ma a kan ƙananan gonaki masu nisa, suna da mahimmanci ga kayan aikin mu, waɗanda aka yi masu araha kuma masu sauƙin amfani da su akan kowane magaryar aladu," in ji Xie.

Ayyukan Bigfish akan rigakafin cututtuka da kawar da su a cikin ƙasa baki ɗaya kuma ya kai ga brucellosis, wanda ya kasance mafi yawan cututtukan zoonotic a duk duniya, da cututtuka a cikin dabbobin abokantaka.

Bigfish ya sauƙaƙe POCT cikin sauri a kusan cibiyoyin kiwon lafiyar dabbobi 4,000 a duk faɗin China. Shuilin Zhu, shugaban kungiyar kare kananan dabbobi ta Zhejiang, ya kara da cewa fasahohin kamfanin na dabbobi.

kiwo da kula da dabbobi ba wai kawai ƙara haɓakar rigakafi da sarrafawa ba, har ma da inganta jin daɗin dabbobi sosai.

Ba da damar ƙaƙƙarfan ƙira ba tare da ƙarin farashi ga masu amfani ba wani fifiko ne a cikin ƙira da ƙirƙira don gwajin ƙwayoyin halittar su. Binciken binciken kwayoyin halittar su GeNext bai fi kwalban ruwa girma ba, kuma yana da nauyin kilogiram 2. Yana fasalta kwakwalwan kwamfuta na mesofluidic da microfluidic waɗanda ke sarrafa matakai masu wahala daga hakar acid nucleic, haɓakar kwayoyin halitta zuwa loda bayanai da bincike na ainihin lokaci.

An rufe shi sosai don guje wa yuwuwar gurɓataccen iska, GeNext 2.0 a yanzu a cikin samar da yawa na iya ba da damar samar da samfur ɗin ya ƙaru daga 1 zuwa 16 a kowane zagaye, jerin da aka yi niyya ya faɗaɗa daga 5 zuwa 25 a kowace gudu, ba tare da ƙarin lokaci ko farashi ba.

"Tsarin mu na GeNext 3.0 zai kara rage lokaci, haɓakawa tare da kwakwalwan kwamfuta na tushen silicon, da kuma haɗa fasahar sarrafa abubuwa kamar jerin nanopore don faɗaɗa mahallin asibiti a cikin gwajin haihuwa da farkon gano cutar kansa," in ji Xie. "Za a iya yin amfani da ƙirarmu na POCT wata rana kowa ya yi amfani da shi, a ko'ina ba tare da la'akari da farashin ba."